These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1037217)

  • 1. Effects of ethyl apovincaminate on the central nervous system.
    Pálosi E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1926-9. PubMed ID: 1037217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General and cerebral haemodynamic activity of ethyl apovincaminate.
    Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical effects of ethyl apovincaminate.
    Rosdy B; Balázs M; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1923-6. PubMed ID: 191039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ethyl apovincaminate on vasospasm of the circulatory isolated internal carotid artery in dogs.
    Mchedlishvili GI; Ormotsadze LG
    Arzneimittelforschung; 1981; 31(3):414-8. PubMed ID: 7194665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia.
    Bencsáth P; Debreczeni L; Takács L
    Arzneimittelforschung; 1976; 26(10a):1920-3. PubMed ID: 1037216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of safety tests of ethyl apovincaminate.
    Cholnoky E; Dömök LI
    Arzneimittelforschung; 1976; 26(10a):1938-44. PubMed ID: 1037220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain.
    Biró K; Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1918-20. PubMed ID: 1037215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the vasodilator effects of ethyl apovincaminate in neurosurgical patients.
    Fényes G; Tarjányi J; Ladvánszky C
    Arzneimittelforschung; 1976; 26(10a):1956-62. PubMed ID: 1037223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of VA-045 on disturbance in consciousness in experimental animal models.
    Okuyama S; Imagawa Y; Ogawa S; Saito Y; Araki H; Otomo S; Sakagawa T; Yamada S; Shima K
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):91-100. PubMed ID: 8272576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation.
    Fényes S; Földes J
    Arzneimittelforschung; 1976; 26(10a):1963-4. PubMed ID: 798589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral pretreatment with ethyl apovincaminate on the cardiac output and nutritive blood flow of various organs in rats.
    Debreczeni L; Takács L
    Arzneimittelforschung; 1976; 26(10a):1912. PubMed ID: 1037213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental study of the effect of Acanthopanax giraldii Harms on the central nervous system].
    Deng HZ; Hou LB; Sun SY; Li SY
    Zhongguo Zhong Yao Za Zhi; 1994 Mar; 19(3):171-4, 192. PubMed ID: 7945845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B; Molnár L; Demeter J; Túry F
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilating effect of ethyl apovincaminate on conjunctival vessels and simultaneous observation of parameters indicating adverse effect.
    Brooser G; Anda L; Domán J
    Arzneimittelforschung; 1976; 26(10a):1975-7. PubMed ID: 1037227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
    Hadjiev D; Yancheva S
    Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neurotropic action of kavinton].
    Trepakov VV; Buldakova SL; Latanov AV; Saakian SA; Iashchenko EA
    Farmakol Toksikol; 1987; 50(4):29-33. PubMed ID: 3499349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of ethyl apovincaminate in the rat.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1933-8. PubMed ID: 1037219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.